N-Succinyl-S-Farnesyl-L-Cysteine, usually shortened to SFC, is a lab-made small molecule used in skincare as a topical anti-inflammatory and anti-aging ingredient. It belongs to a class called isoprenylcysteine analogs, or IPCs. In plain terms, it’s the amino acid cysteine joined to a farnesyl group (a fatty, oil-loving chain) and capped with a succinyl group. Researchers have been studying small IPC molecules as a possible new class of topical anti-inflammatories for about 15 years. SFC is one of the newer members of that family.
The structure explains how it works. The farnesyl chain attached to cysteine mimics the tail end of certain processed proteins inside cells. That mimicry lets IPCs interfere with signaling that drives inflammation. The class has been shown to inhibit G-protein coupled receptor activity in skin. These receptors sit on cell surfaces and help trigger inflammatory responses. In lab work, SFC reduced GPCR-induced oxidation in differentiated neutrophils, which are immune cells that release damaging oxygen species when activated. Researchers also tested it on dermal fibroblasts, keratinocytes, and dermal endothelial cells exposed to triggers that raise reactive oxygen species, cytokines, and collagenase. Collagenase matters here because it breaks down collagen.
SFC has some human data behind it too. In a 49-person randomized, double-blind, vehicle-controlled split-face trial, subjects applied 1% SFC gel, 5% niacinamide, or a vehicle for 12 weeks. The 1% SFC gel beat the vehicle on wrinkle reduction, hydration, texture, and overall skin appearance. The authors describe it as the first farnesyl-cysteine IPC shown to clinically improve appearance and signs of aging. A later 2023 pilot study in the Journal of Cosmetic Dermatology reported reduced redness and inflammatory lesions in rosacea subjects. It’s related to N-Acetyl-S-farnesyl-L-cysteine (AFC), the first IPC discovered, which some readers may recognize from earlier anti-redness products.
Sources:
- MDPI Cosmetics, Fernández et al. 2021
- Princeton Molecular Biology publication listing
- Princeton rosacea pilot study listing
- Cosmetics (Nov 2021)
